Annual Revenue
$886.00 K
-$1.44 M-61.96%
31 December 2023
Summary:
Spyre Therapeutics annual revenue is currently $886.00 thousand, with the most recent change of -$1.44 million (-61.96%) on 31 December 2023. During the last 3 years, it has fallen by -$17.85 million (-95.27%). SYRE annual revenue is now -95.27% below its all-time high of $18.74 million, reached on 01 December 2021.SYRE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
Spyre Therapeutics quarterly revenue is not available.SYRE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
Spyre Therapeutics TTM revenue is not available.SYRE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -62.0% | - | - |
| 3 y3 years | -95.3% | - | - |
| 5 y5 years | - | - | - |
SYRE Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -95.3% | at low | ||||
| 5 y | 5 years | -95.3% | at low | ||||
| alltime | all time | -95.3% | at low |
Spyre Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $886.00 K(-62.0%) | - | - |
| June 2023 | - | $688.00 K(+247.5%) | $1.23 M(+5.4%) |
| Mar 2023 | - | $198.00 K(+17.9%) | $1.17 M(-50.0%) |
| Dec 2022 | $2.33 M(-87.6%) | - | - |
| Dec 2022 | - | $168.00 K(-3.4%) | $2.33 M(-59.9%) |
| Sept 2022 | - | $174.00 K(-72.2%) | $5.80 M(-17.4%) |
| June 2022 | - | $625.00 K(-54.1%) | $7.03 M(-65.0%) |
| Mar 2022 | - | $1.36 M(-62.6%) | $20.10 M(+7.3%) |
| Dec 2021 | $18.74 M(+382.0%) | $3.64 M(+160.5%) | $18.74 M(+24.1%) |
| Sept 2021 | - | $1.40 M(-89.8%) | $15.10 M(+10.2%) |
| June 2021 | - | $13.70 M(+475.9%) | $13.70 M(+106.5%) |
| Dec 2018 | $3.89 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $2.38 M(+57.5%) | $6.63 M(+15.7%) |
| Mar 2018 | - | $1.51 M(+1.9%) | $5.73 M(+10.1%) |
| Dec 2017 | $5.21 M(+12.5%) | $1.48 M(+17.5%) | $5.20 M(+4.7%) |
| Sept 2017 | - | $1.26 M(-14.7%) | $4.97 M(+2.3%) |
| June 2017 | - | $1.48 M(+50.6%) | $4.86 M(+2.2%) |
| Mar 2017 | - | $982.00 K(-21.3%) | $4.75 M(+2.7%) |
| Dec 2016 | $4.63 M(-23.9%) | $1.25 M(+8.5%) | $4.63 M(-6.8%) |
| Sept 2016 | - | $1.15 M(-16.3%) | $4.97 M(+1.6%) |
| June 2016 | - | $1.37 M(+59.8%) | $4.89 M(-29.6%) |
| Mar 2016 | - | $859.00 K(-45.8%) | $6.94 M(+14.1%) |
| Dec 2015 | $6.08 M | $1.58 M(+47.7%) | $6.08 M(+35.2%) |
| Sept 2015 | - | $1.07 M(-68.7%) | $4.50 M(+31.3%) |
| June 2015 | - | $3.43 M | $3.43 M |
FAQ
- What is Spyre Therapeutics annual revenue?
- What is the all time high annual revenue for Spyre Therapeutics?
- What is Spyre Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Spyre Therapeutics?
- What is the all time high TTM revenue for Spyre Therapeutics?
What is Spyre Therapeutics annual revenue?
The current annual revenue of SYRE is $886.00 K
What is the all time high annual revenue for Spyre Therapeutics?
Spyre Therapeutics all-time high annual revenue is $18.74 M
What is Spyre Therapeutics annual revenue year-on-year change?
Over the past year, SYRE annual revenue has changed by -$1.44 M (-61.96%)
What is the all time high quarterly revenue for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly revenue is $13.70 M
What is the all time high TTM revenue for Spyre Therapeutics?
Spyre Therapeutics all-time high TTM revenue is $20.10 M